You probably know someone whose knees creak on every step down the stairs, or whose fingers stiffen each morning. For most of them, the answers are painkillers, exercise and patience. No pill on the shelf actually slows the damage inside the joint.
That may be starting to shift. Researchers at Yale University School of Medicine screened roughly 980 approved drugs for ones that could calm osteoarthritis inflammation. The one that stood out was dabigatran, the active ingredient in the oral blood thinner Pradaxa.
In mice and in macaques, dabigatran reduced joint inflammation and cartilage damage. The work was published on November 11, 2026, in the journal Science Translational Medicine.
According to the CDC, about 33 million US adults live with osteoarthritis, and there is no cure. Today's care focuses on easing pain and keeping the joint moving. A drug that slowed the disease itself would be a real shift.
Also read: Forget sleeping pills: This tiny patch could be the future of better sleep
How a clot pill ended up acting on joint inflammation
The Yale team was hunting for compounds that could quiet two inflammatory signals tied to osteoarthritis, called TNF-α and IL-1β. These are chemical messengers that help drive the slow breakdown of cartilage.
Dabigatran turned out to act on a protein inside cells called BIG2. BIG2 helps control which inflammation receptors sit on a cell's outer surface. With dabigatran attached, the cell pushed one receptor out and broke the other one down, muting both signals at once.
In mice with surgically induced osteoarthritis, the drug eased cartilage damage and pain-related behavior. In cynomolgus macaques with the same kind of joint injury, oral dabigatran helped preserve cartilage and the animals walked better.
What this means for people with joint pain today
Nothing immediate. These were animal studies, and the researchers are clear that human trials have not been done. Dabigatran is approved in the US to prevent strokes and clots, and its main risk is serious bleeding.
Also read: One long walk or several short ones? Study reveals which is better for blood sugar
Any plan to use it for a joint disease would have to weigh that bleeding risk, especially in older people who often take other medicines. The authors also note that animal models cannot fully capture how osteoarthritis develops in people.
Still, repurposing a drug doctors already know well is faster than building a new one from scratch. If the findings hold up, BIG2 itself may become a target for a dedicated osteoarthritis therapy.
Also read: What happens to your cholesterol when you drink milk every day?
This article is made and published by Mie Hermansen, who may have used AI in the preparation.
